Neoplasms Clinical Trials in Philadelphia, Pennsylvania
6 studies are recruiting for neoplasms in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o…
- Stage
- Phase 2
- Ages
- Any age
- Site
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania
- Locations
- 222 in total
- Run by
- Celgene
-
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
The purpose of this study is to characterize safety and to determine the Recommended Phase 2 Dose (RP2D[s]) and optimal dosing schedule(s) of JNJ-88549968 in part 1 (Dose Escalation); to characterize the safety of JNJ- 88549968 at RP2D(s) in part 2 (Cohort Expansion). For U.S. sites: the purpose of…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- University of Pennsylvania, Philadelphia, Pennsylvania
- Locations
- 41 in total
- Run by
- Janssen Research & Development, LLC
-
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
The purpose of this study is to determine the safety, feasibility, recommended dose(s) and regimen(s) of JNJ-87704916 as monotherapy and in combination with cetrelimab.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Fox Chase Cancer Center, Philadelphia, Pennsylvania
- Locations
- 10 in total
- Run by
- Johnson & Johnson Enterprise Innovation Inc.
-
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under this master protocol define drug/disease-specific research goals and activities to test them. New stu…
- Stage
- Phase 2
- Ages
- 1 to 39
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 72 in total
- Run by
- Eli Lilly and Company
-
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
The purpose of this study is to investigate a new drug GSK5533524 in adults with certain advanced cancers to find a safe dose and learn how well people tolerate it, so researchers can choose the best dose for the next stage of testing. The study will also check whether the drug can shrink tumours o…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- GSK Investigational Site, Philadelphia, Pennsylvania
- Locations
- 16 in total
- Run by
- GlaxoSmithKline
-
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients wit…
- Stage
- Not phased
- Ages
- Any age
- Site
- Philadelphia CyberKnife, Philadelphia, Pennsylvania
- Locations
- 13 in total
- Run by
- The Radiosurgery Society
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.